Vis enkel innførsel

dc.contributor.authorHigginson, Irene J.
dc.contributor.authorEvans, Catherine J.
dc.contributor.authorGrande, Gunn
dc.contributor.authorPreston, Nancy
dc.contributor.authorMorgan, Myfanwy
dc.contributor.authorMcCrone, Paul
dc.contributor.authorLewis, Penney
dc.contributor.authorFayers, Peter
dc.contributor.authorHarding, Richard
dc.contributor.authorHotopf, Matthew
dc.contributor.authorMurray, Scott A.
dc.contributor.authorBenalia, Hamid
dc.contributor.authorGysels, Marjolein
dc.contributor.authorFarquhar, Morag
dc.contributor.authorTodd, Chris
dc.date.accessioned2019-10-25T09:19:54Z
dc.date.available2019-10-25T09:19:54Z
dc.date.created2013-07-23T11:12:15Z
dc.date.issued2013
dc.identifier.citationBMC Medicine. 2013, 11:111 .nb_NO
dc.identifier.issn1741-7015
dc.identifier.urihttp://hdl.handle.net/11250/2624400
dc.description.abstractBackground Despite being a core business of medicine, end of life care (EoLC) is neglected. It is hampered by research that is difficult to conduct with no common standards. We aimed to develop evidence-based guidance on the best methods for the design and conduct of research on EoLC to further knowledge in the field. Methods The Methods Of Researching End of life Care (MORECare) project built on the Medical Research Council guidance on the development and evaluation of complex circumstances. We conducted systematic literature reviews, transparent expert consultations (TEC) involving consensus methods of nominal group and online voting, and stakeholder workshops to identify challenges and best practice in EoLC research, including: participation recruitment, ethics, attrition, integration of mixed methods, complex outcomes and economic evaluation. We synthesised all findings to develop a guidance statement on the best methods to research EoLC. Results We integrated data from three systematic reviews and five TECs with 133 online responses. We recommend research designs extending beyond randomised trials and encompassing mixed methods. Patients and families value participation in research, and consumer or patient collaboration in developing studies can resolve some ethical concerns. It is ethically desirable to offer patients and families the opportunity to participate in research. Outcome measures should be short, responsive to change and ideally used for both clinical practice and research. Attrition should be anticipated in studies and may affirm inclusion of the relevant population, but careful reporting is necessitated using a new classification. Eventual implementation requires consideration at all stages of the project. Conclusions The MORECare statement provides 36 best practice solutions for research evaluating services and treatments in EoLC to improve study quality and set the standard for future research. The statement may be used alongside existing statements and provides a first step in setting common, much needed standards for evaluative research in EoLC. These are relevant to those undertaking research, trainee researchers, research funders, ethical committees and editors.nb_NO
dc.language.isoengnb_NO
dc.publisherBMC (part of Springer Nature)nb_NO
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleEvaluating complex interventions in End of Life Care: the MORECare Statement on good practice generated by a synthesis of transparent expert consultations and systematic reviewsnb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.description.versionpublishedVersionnb_NO
dc.source.pagenumber11nb_NO
dc.source.volume11:111nb_NO
dc.source.journalBMC Medicinenb_NO
dc.identifier.doi10.1186/1741-7015-11-111
dc.identifier.cristin1039971
dc.description.localcode© 2013 Higginson et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.nb_NO
cristin.unitcode194,65,15,0
cristin.unitnameInstitutt for klinisk og molekylær medisin
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal